Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT

Completed

• Conditions: Hepatocellular Carcinoma

• Registration Number: NCT05045573
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

The aim of our study is to analyze pathological analysis of surgically treated aggressive hepatocellular carcinomas after radio-embolization.

The investigators aim to demonstrate that a higher dose results in better tumor response while respecting safety conditions, that is, no radiologically induced liver disease.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01-01
• Primary Completion: 2021-08-01
• Study Completion: 2021-08-30
• Status Verified: 2021-09
• Study First Submitted: 2021-09-06
• Study First Submitted QC: 2021-09-14
• Study First Posted: 2021-09-16
• Last Update Submitted: 2021-09-29
• Last Update Posted: 2021-10-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pathological tumor response	6 months	Patients are treated with SIRT, then if the tumor response was adequate, surgery was performed.Analysis after surgery. (6 months after SIRT)

Secondary Outcome Measures

Name	Time	Method
Rate of Healthy liver hypertrophia	day 1	Rate of Healthy liver hypertrophia

Trial Locations

Locations (1)

Uhmontpellier; 🇫🇷 Montpellier, France